Vesna Blazevic

Author PubWeight™ 12.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particles. Immunology 2012 1.12
2 Primary cutaneous T-cell lymphomas show a deletion or translocation affecting NAV3, the human UNC-53 homologue. Cancer Res 2005 1.12
3 Norovirus GII-4 causes a more severe gastroenteritis than other noroviruses in young children. J Infect Dis 2011 1.03
4 Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice. PLoS One 2013 1.02
5 Cross-clade protection induced by human immunodeficiency virus-1 DNA immunogens expressing consensus sequences of multiple genes and epitopes from subtypes A, B, C, and FGH. Viral Immunol 2005 0.94
6 Noroviruses as a major cause of acute gastroenteritis in children in Finland, 2009-2010. Scand J Infect Dis 2011 0.92
7 Production and characterization of virus-like particles and the P domain protein of GII.4 norovirus. J Virol Methods 2011 0.89
8 A DNA HIV-1 vaccine based on a fusion gene expressing non-structural and structural genes of consensus sequence of the A-C subtypes and the ancestor sequence of the F-H subtypes. Preclinical and clinical studies. Microbes Infect 2005 0.87
9 Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles. Hum Vaccin Immunother 2013 0.84
10 Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo. Hum Vaccin Immunother 2014 0.83
11 Combining DNA technologies and different modes of immunization for induction of humoral and cellular anti-HIV-1 immune responses. Vaccine 2008 0.81
12 Protection against live rotavirus challenge in mice induced by parenteral and mucosal delivery of VP6 subunit rotavirus vaccine. Arch Virol 2015 0.80
13 Pre-existing immunity to norovirus GII-4 virus-like particles does not impair de novo immune responses to norovirus GII-12 genotype. Viral Immunol 2013 0.78
14 GTU-MultiHIV DNA vaccine results in protection in a novel P815 tumor challenge model. Vaccine 2007 0.76
15 Immunization with dendritic cells transfected in vivo with HIV-1 plasmid DNA induces HIV-1-specific immune responses. Arch Virol 2011 0.75